Press Releases
U.S. Food and Drug Administration Approves ABILIFY (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
Business Wire | 1 day 21 hours 41 minutes ago
Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.... (more)
NUCRYST Announces Special Meeting of Shareholders
PRNewswire | 1 day 22 hours 11 minutes ago
PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. announced today that a Special Meeting of Shareholders will be held on Monday, December 21, 2009. The purpose of the Meeting is to consider approval of two special resolutions. The first special resolution is to approve and authorize the sale of all or substantially all of the assets of NUCRYST, substantially on the terms provided for in the asset purchase agreement dated November 10, 2009 among the NUCRYST Pharmace...... (more)
Zacks Analyst Blog Highlights: Aetna Inc., UnitedHealth Group Inc., WellPoint Inc., Assurant Inc. and Cigna Corp
Business Wire | 1 day 23 hours 41 minutes ago
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Aetna Inc. (NYSE: AET), UnitedHealth Group Inc. (NYSE: UNH), WellPoint Inc. (NYSE: WLP), Assurant Inc. (NYSE: AIZ) and Cigna Corp (NYSE: CI).... (more)
Lannett Reauthorizes Stock Repurchase Program
Business Wire | 2 days 1 hour 41 minutes ago
Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase program. Under the program, the company is authorized to repurchase up to $5 million of Lannett’s outstanding common stock from time to time in open market and privately negotiated transactions.... (more)
Reportlinker Adds Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015
PRNewswire | 2 days 4 hours 11 minutes ago
... (more)
Reportlinker Adds Medical Specialty Bags - Global Market Trends
PRNewswire | 2 days 5 hours 41 minutes ago
... (more)
Reportlinker Adds Stethoscopes - A Worldwide Market Intelligence Report
PRNewswire | 2 days 5 hours 41 minutes ago
... (more)
AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured
PRNewswire | 2 days 6 hours 10 minutes ago
... (more)
Biotel Announced Profitable First Quarter Ended September 30, 2009
PRNewswire | 2 days 6 hours 11 minutes ago
... (more)
77 Press Releases |
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
[Forum] I'm a Big Active Guy but Can't Lose Weight
Diet-Blog
Get Your Eggos Before They Run Out
Diet-Blog
Money-Driven Medicine film now downloadable
Health Care Blog, The
The Senate Bill: Medicare And Much Else
Health Affairs Blog
Companies in the news
- Actelion Ltd
- Aetna Incorporated
- Affymax Inc.
- AstraZeneca PLC
- Bayer Schering Pharma
- China Medical Technologies Inc
- Coventry Health Care Inc
- Genzyme
- GlaxoSmithKline plc
- Merck & Co.
- Nabi Biopharmaceuticals
- Pfizer
- Regeneron Pharmaceutical
- Vivus Inc.
- Watson Pharmaceuticals
